Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Cost of Revenue: 2019-2024

Historic Cost of Revenue for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $15.6 million.

  • Biodesix's Cost of Revenue fell 1.75% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 10.80%. This contributed to the annual value of $15.6 million for FY2024, which is 19.70% up from last year.
  • As of FY2024, Biodesix's Cost of Revenue stood at $15.6 million, which was up 19.70% from $13.0 million recorded in FY2023.
  • Over the past 5 years, Biodesix's Cost of Revenue peaked at $30.5 million during FY2021, and registered a low of $13.0 million during FY2023.
  • In the last 3 years, Biodesix's Cost of Revenue had a median value of $14.2 million in 2022 and averaged $14.2 million.
  • As far as peak fluctuations go, Biodesix's Cost of Revenue soared by 262.17% in 2020, and later plummeted by 53.62% in 2022.
  • Yearly analysis of 5 years shows Biodesix's Cost of Revenue stood at $22.0 million in 2020, then skyrocketed by 38.73% to $30.5 million in 2021, then plummeted by 53.62% to $14.2 million in 2022, then declined by 8.08% to $13.0 million in 2023, then grew by 19.70% to $15.6 million in 2024.